Federal award (BPA CALL, fiscal year 2021)
Recipient: CERILLIANT CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-07-26 to 2022-09-30
Current total value of award: $14919.4
Description: PRODUCTS WILL BE USED FOR SCREENING AND ATION OF SUSPECTED DRUG USE IN SERVICE MEMBER AND/OR POST-MORTEM URINE, BLOOD AND TISSUE SAMPLES.